Related Experiment Videos
Adenosine, the heart, and coronary circulation
1First Department of Medicine, Osaka University School of Medicine, Japan.
Insights
Adenosine, a key molecule in heart function, dilates coronary vessels and protects against ischemia/reperfusion injury by counteracting harmful cellular responses. Further clinical studies are needed to confirm its therapeutic potential.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Adenosine regulates myocardial and coronary circulation via A1 and A2 receptors.
- A1 receptors inhibit adenylyl cyclase; A2 receptors stimulate it.
- Adenosine's role in increased myocardial oxygen demand remains debated.
Purpose of the Study:
- To explore the multifaceted roles of adenosine in cardiovascular regulation.
- To elucidate adenosine's protective mechanisms against ischemia/reperfusion injury.
- To assess the potential therapeutic benefits of adenosine in cardiac conditions.
Main Methods:
- Review of existing literature on adenosine's physiological effects.
- Analysis of adenosine receptor subtypes and signaling pathways.
- Examination of adenosine's impact on myocardial oxygen demand and ischemia/reperfusion.
Main Results:
- Adenosine dilates coronary vessels and modulates myocardial contractility and nodal activity.
- Adenosine attenuates ischemia/reperfusion injury by inhibiting leukocytes, platelets, and catecholamine release.
- Adenosine limits myocardial stunning and infarct size.
Conclusions:
- Adenosine exhibits significant protective effects against ischemia/reperfusion injury.
- Adenosine administration or potentiation may offer therapeutic benefits for cardiac ischemia.
- Further clinical investigation is warranted to validate adenosine's clinical utility.
Abstract:
Adenosine is known to regulate myocardial and coronary circulatory functions. Adenosine not only dilates coronary vessels, but attenuates beta-adrenergic receptor-mediated increases in myocardial contractility and depresses both sinoatrial and atrioventricular node activities. The effects of adenosine are mediated by two distinct receptors (i.e., A1 and A2 receptors). A1 adenosine receptors, located in atrial and ventricular myocardium and sinoatrial/atrioventricular nodes, are responsible for inhibition of adenylyl cyclase activity. A2 adenosine receptors, located in coronary endothelial and smooth muscle cells, are responsible for stimulation of this enzyme activity. During increased myocardial oxygen demand due to rapid pacing and exercise, although both coronary blood flow and adenosine concentrations in the myocardium and coronary efflux increased, there is no clear consensus explaining its cause and effect relation at present. However, ischemia/reperfusion-induced coronary hyperemia is believed to be mostly attributed to released adenosine, and it has been proven that adenosine attenuates the severity of ischemia due to its coronary vasodilatory action. The beneficial effects of adenosine during ischemia/reperfusion processes do not seem simple. This is because myocardial ischemia and reperfusion injury is caused by 1) activated leukocytes and platelets, 2) ATP depletion and calcium overload of myocardium, and 3) catecholamine release from the presynaptic nerves as well as 4) the impaired coronary circulation. Intriguingly adenosine attenuates all of these deleterious actions and thereby attenuates ischemia/reperfusion injury. Indeed, adenosine attenuates the severity of contractile dysfunction (myocardial stunning) and limits the infarct size. Thus, administration of adenosine or potentiators of adenosine production in the ischemic myocardium may be beneficial for the attenuation of ischemic and reperfusion injuries, although further clinical investigations are necessary.